Pure Global

Application of Frailty Prevention Care Management Program of Community Elderly Adults - Trial NCT05883423

Access comprehensive clinical trial information for NCT05883423 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung Memorial Hospital and is currently Not yet recruiting. The study focuses on Frailty. Target enrollment is 70 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05883423
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT05883423
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Application of Frailty Prevention Care Management Program of Community Elderly Adults
Application of Frailty Prevention Care Management Program on Frailty and Health Function of Community Elderly Adults

Study Focus

Frailty

FPCMP-Old Age

Interventional

other

Sponsor & Location

Chang Gung Memorial Hospital

Chiayi City, Taiwan

Timeline & Enrollment

N/A

Jun 01, 2023

Dec 31, 2023

70 participants

Primary Outcome

The Taiwanese version of Tilburg frailty indicator(TFI-T),Chronic Disease and Health Problems Scale,Health Function,Nutritional Assessment

Summary

This study first explored the relationship between basic demographic variables, frailty and
 health function of community-based adults and elderly. Promote and explore the effect of the
 Frailty Prevention Care Management Program (FPCMP-Old Age) on the frailty and health function
 of the elderly in the community.
 
 The elderly in the long-term care community bases in the central and southern regions were
 selected as the object of acceptance. The study design is divided into two years(Two phases)
 study, the first phase is to develop a 12-week frailty prevention care management plan
 (FPCMP-Old Age). The second stage is to introduce FPCMP-Old Age to carry out a pilot study in
 the south-central community. A total of 70 cases were accepted in the experimental group and
 the control group. This study was divided into two groups, which were grouped by convenient
 sampling. The experimental group underwent the FPCMP-Old Ag program; the control group only
 maintained the original site to delay disability and dementia activities. In this study,
 pre-intervention, post-intervention, and four-week follow-up were conducted, and three
 questionnaires were evaluated. Each time it was estimated to spend 30 minutes for each
 answer, the activity lasted for 12 weeks. The execution period this time is from January 1,
 2023 to December 30, 2024, but the time for accepting cases is from June 1, 2023 to December
 31, 2023. There are four research tools in this study, namely: demographic variables, chronic
 disease and health problem scale, frailty detection tool (TFI-T), health function (refer to
 the 2016 recommendation of the Ministry of Education and Sports Administration for the
 fitness of the elderly group Test items, testing the subject's body composition, upper and
 lower limb muscle strength, upper and lower limb flexibility, cardiorespiratory endurance,
 dynamic and static balance) and nutritional status (mini nutritional assessment) and other
 tools. Data were collected in triplicate, and generalized estimating equations were used to
 analyze whether there were differences in interaction effects between groups, within groups,
 and time.
 
 The Frailty Prevention Care Management Program (FPCMP-Old Age) can help community-based
 adults and older adults reduce frailty and improve health function.

ICD-10 Classifications

Unattended death
Individuals with autosomal fragile site

Data Source

ClinicalTrials.gov

NCT05883423

Non-Device Trial